 |
Genomics
at FDA
Pharmacogenomics Education Initiatives
The FDA has organized various workshops (see
Upcoming Events for future workshops and
Publications for proceedings from past workshops) with PhRMA, BIO and other
organizations designed to both educate and provide feedback on
pharmacogenomics. In addition, a number of articles have been
published, encouraging a broad public education in pharmacogenomics
and personalized medicine.
A new lecture series entitled
“Pharmacogenomics from the Ground Up” designed for scientists with
diverse academic and professional backgrounds is being held
regularly and has been integrated into the ongoing education for
reviewers within CDER. So far, the course is set up in three
sessions
Additional
continuing education lecture series are planned to include speakers
from the diagnostic and pharmaceutical industries responsible for
the development of molecular diagnostics and of drugs for which pharmacogenomic data made a difference in therapeutic efficacy or
safety.
Please contact us via email: fdagenomics@cder.fda.gov for the presentations and more information on pharmacogenomics.
2009
- "Human Leukocyte antigens (HLAs) and adverse drug reactions (ADRs)" Shashi Amur, Ph.D, CDER April 2009, Walter Reed Army Institute of Research (WRAIR), MD presentations
2008
- "Pharmacogenomics Information in Drug Labels and Re-labeling efforts at FDA" Shashi Amur, Ph.D. and Padmaja Mummaneni, Ph.D., CDER, December 2008 Temple University, PA presentation
2007
2005
 PDF requires the free Adobe
Acrobat Reader
 Back
to Top 
Back to Genomics
Date created: March 22, 2005; updated May 11, 2009 |
|
